Drug regulation overseas the ongoing assessment of product safety, efficacy, and quality and promotes the development and availability of new and better products to protect public health. Globalisation of drug development challenges regulators and the regulated industry around the world. Harmonisation of requirements, mutual recognition of evaluations and other means of work sharing are strategies for keeping pace with the progress of globalisation.
In this context, a new strategic regulatory approach and greater harmonisation, coordination and alignment of regulatory rules among nations is evolving.
Join us to learn how collaboration of pharmaceutical industries and health authorities foster global streamlining of marketing authorisation.